Memorial Sloan-Kettering Cancer Center;St. Jude Children's Research Hospital
发明人:
申请号：
EP15773170.4
公开号：
EP3126525A4
申请日:
2015.04.02
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
A method of determining sensitivity to cancer treatment includes the step of determining the presence of overexpression of MYC in a biological sample from a patient suffering from cancer, wherein the presence of overexpression of MYC indicates a sensitivity to a treatment by a CDK9 inhibitor and wherein the cancer is selected from the group consisting of carcinoma, leukemia, and lymphoma.
